Posts

Showing posts from September, 2017

Patients with TB and HIV should receive prompt coordinated treatment for both conditions

People with HIV or diabetes, who are taking immune-suppressing medications, or who smoke or abuse drugs, are at higher risk for developing TB disease once infected. Patients often are diagnosed with HIV and TB at the same time. In 2003, when the previous TB guidelines were developed, patients with HIV usually did not start their anti-retroviral therapy (ART) until after TB treatment was completed, unless the immunosuppression from HIV-infection progressed. Recommendations for timing of initiation of ART have since changed. "Data from numerous trials have made it very clear that patients with HIV should begin treatment with anti-retroviral therapy (ART) during TB treatment, and not wait until after TB therapy is completed," said Payam Nahid, M.D., M.P.H., lead author of the guidelines and professor of medicine at the University of California, San Francisco School of Medicine. "Research shows that all patients with TB and HIV should receive treatment for both conditi...

Disrupting mitochondrial perform may enhance therapy of fungal infections

"Our research adds weight to the idea that effective antifungal drugs can target even those mitochondrial proteins that are highly conserved in humans and fungi, and that this could be a way to make a broad spectrum antifungal combination therapy that would be less susceptible to resistance," says Benjamin Vincent, a former graduate student in Whitehead Member Susan Lindquist's lab who is now a scientist at Yumanity Therapeutics. Fungi cause bothersome diaper rashes, oral thrush , athlete's foot, and vaginal yeast infections, but they are also responsible for life-threatening infections in the immunocompromised, including patients receiving transplants, people with HIV/AIDS, cancer patients, and the elderly. Severe invasive fungal infections have a mortality rate of 30-50% and cause an estimated 1.5 million deaths worldwide annually. Doctors rely on three main drug classes -- the azoles (e.g., fluconazole), the echinocandins, and amphotericin -- to treat thes...

Risk factors, features and outcomes of invasive non-typhoidal Salmonella in Vietnam

Image
MLST profiling of invasive Non-typhoidal Salmonella in Vietnam. Credit score: Tu Le Thi Phuong Invasive   non-typhoidal Salmonella  (iNTS) infections happen when  Salmonella  micro organism, which usually trigger diarrhea, enter the bloodstream and unfold by means of the physique.  iNTS  infections could trigger sickness and loss of life in malaria-stricken kids and HIV-infected adults in sub-Saharan Africa, however little is thought in regards to the prevalence and severity of  iNTS  in Asia. A examine revealed in  PLOS Uncared for Tropical Illnesses  means that  iNTS  illness, like in sub-Saharan Africa, is a extreme an infection with a excessive mortality charge in Vietnam. Stephen Baker, Corinne Thompson, and Nguyen Phu Huong Lan, working at The Hospital for Tropical Illnesses and Oxford College Medical Analysis Unit in Ho Chi Minh Metropolis, Vietn...

Roadblocks to analysis: bioethicist addresses lack of HIV research in pregnant ladies

Lyerly, associate director of the UNC Center for Bioethics and associate professor of social medicine at the UNC School of Medicine, is also an obstetrician/gynecologist who studies ethically complex clinical and policy issues related to women's reproductive health. In the August issue of the  AIDS , Lyerly addresses the lack of research of HIV-positive pregnant women and pregnant women who are at risk of contracting HIV, which has "led to a dearth of evidence to guide safe and effective treatment and prevention of HIV in pregnancy, " Lyerly wrote. In the research on the HIV-positive pregnant women that has been done, most outcomes focus entirely on the health of the fetus. Pregnant women are excluded from the vast majority of studies, including studies on how to best prevent HIV. This lack of research has resulted in "major gaps in understanding how best to address the health needs of pregnant women living with or at risk for HIV," she said. To help ad...

Emtricitabine/tenofovir alafenamide in HIV infection: Added benefit not proven

The drug mixture emtricitabine/ tenofovir alafenamide is permitted together with different antiviral brokers for the remedy of adults and adolescents contaminated with human immunodeficiency virus sort 1 (HIV-1). In an early profit evaluation, the German Institute for High quality and Effectivity in Well being Care (IQWiG) has now examined whether or not in these sufferers this mix provides benefits over the suitable comparator remedy. Based on the findings, such an additional benefit just isn't confirmed: No knowledge have been obtainable for 2 of 4 analysis questions; the research submitted for the third analysis query deviated from the suitable comparator remedy; higher hurt for sure sufferers was proven within the fourth analysis query. No related knowledge for adolescents The Federal Joint Committee (G-BA) differentiated between 4 teams of sufferers in response to age and remedy standing. Two teams -- pretreate...

Study finds better definition of homelessness may help minimize HIV risk

Even from a research standpoint, definitions across various studies lack consistency, according to Elizabeth Bowen, an assistant professor in the University at Buffalo School of Social Work, whose new study published in the  Journal of HIV/AIDS & Social Work  suggests how understanding housing histories and the multiple dimensions of homelessness can help better identify who might be at greater risk of transmitting or contracting HIV. "The homeless population can't be painted with a broad brush because there will be people within that group who have more stability than others," she said. "This study came of wanting to break down what it means to be homeless and linking that with HIV risk behaviors." Bowen's research looked specifically at residents of single-room occupancy (SRO) housing in Chicago, a group that illustrates the difficulty of assigning a unified definition of homelessness. Bowen says there is a subset of the SRO group that consi...

New global migration mapping to help fight against infectious diseases

Image
'Estimated inner human migration flows between subnational administrative models for each malaria endemic nation in Africa.' Credit score: WorldPop Geographers on the College of Southampton have accomplished a big scale knowledge and mapping venture to trace the move of inner human migration in low and center earnings international locations. Researchers from the WorldPop venture on the College have, for the primary time, mapped estimated inner migration in international locations throughout three continents; Africa, Asia and Latin America and the Caribbean. Professor Andy Tatem, Director of WorldPop , feedback: "Understanding how persons are transferring round inside international locations is significant in combating infectious illnesses like malaria. The parasite which causes the illness could be rapidly reintroduced to a malaria free space by extremely cell populations. "Having an correc...

New understanding of pulmonary hypertension leads to promising drug targets

"If we aim to cure this disease, the next set of medications and treatments should be those that target the origin at the molecular level," said Stephen Y. Chan, M.D., Ph.D., director of the UPMC Center for Pulmonary Vascular Biology and Medicine at the Vascular Medicine Institute at Pitt, and senior author of the study. "As a community, we are struggling right now to understand those origins of PH, and this study aimed to address that untapped need." Affecting tens of millions of people worldwide, PH is high blood pressure in the arteries in the lungs, which makes it difficult for blood to flow from the heart to the lungs. Symptoms of the disease, which can lead to heart failure, include shortness of breath, fatigue and chest pain; and, in its early stages, might not be noticeable for months or even years. Often a life-threatening condition, it becomes progressively worse, making early and accurate diagnosis important to allow treatments that extend and impr...

Mutational tug of war over HIV's disease-inducing potential

Examining HIV transmission events occurring in 169 heterosexual couples in Zambia, the researchers found that almost a third of potential immune target sites in the virus that established infection were "pre-adapted" to the immune response in the newly-infected partner. That means that HIV had already evolved to evade immune scrutiny in the newly-infected person. The researchers' findings suggest that designers of vaccines against HIV should focus on regions of conserved viral proteins that do not become adapted in the same way. The study, published Monday, Aug. 22 in  Journal of Experimental Medicine , was led by Eric Hunter, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine, Emory Vaccine Center and Yerkes National Primate Research Center. Hunter is a Georgia Research Alliance Eminent Scholar and co-director of the Emory Center for AIDS Research. The first author is postdoctoral fellow Daniela C. Mónaco, PhD. This analys...

New blood spot test used internationally in fight against HIV

Image
A 3mm punch is taken from a dried blood spot and despatched to the lab to evaluate PrEP drug ranges. Credit score: CU Anschutz Medical Campus Researchers on the Skaggs College of Pharmacy and Pharmaceutical Sciences at CU Anschutz have developed a way that estimates an HIV-negative affected person's adherence to medication prescribed to stop HIV transmission throughout intercourse. The take a look at measures traces of antiretroviral medication in a spot of dried blood to find out how a lot pre-exposure prophylactic, or PrEP, drugs a affected person has used. Truvada, the one FDA-approved antiretroviral PrEP drug for HIV prevention, is confirmed greater than 90 % efficient in stopping HIV transmission throughout intercourse -- in those that use it persistently. The assay method supplies an goal technique to inform if sufferers are utilizing PrEP persistently. "There is a have to objectively measure PrEP...